EP Q3 2025 Earnings Loss Per Share Reported Amid Ongoing Industry Headwinds Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage FOXA Q1 2026 Earnings EPS Surges Past Estimates with 339 Beat SMR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Stock Barely Moves Mercury General Corporation Q1 2026 Earnings Strong Earnings Beat Driven by Underwriting Discipline PRAX Q1 2026 Earnings EPS Beat Amid Continued RD Focus